DNA (Deoxyribonucleic acid) comprises the blueprints of life. Within the structure of DNA, there are codes which are required for the assembly of proteins and non-coding RNA; these molecular machineries are responsible for affecting the biological systems that are creating and maintaining life.
Wilmington, Delaware, United States, Transparency Market Research Inc. – DNA (Deoxyribonucleic acid) comprises the blueprints of life. Within the structure of DNA, there are codes which are required for the assembly of proteins and non-coding RNA; these molecular machineries are responsible for affecting the biological systems that are creating and maintaining life.
Read Report Overview – https://www.transparencymarketresearch.com/next-generation-sequencing-services-market.html
By understanding the DNA sequence, researchers have been able to interpret the structure and function of proteins, RNA, and have also gained an understanding of the underlying causes of diseases. Next-Generation Sequencing (NGS) is a powerful platform that enables the sequencing of a large number of DNA molecules simultaneously. It is a high-throughput methodology that enables rapid sequencing of samples consisting of DNA or RNA base pairs.
NGS supports a broad range of applications including, chromosome counting, gene expression profiling, molecular analysis, and detection of epigenetic changes. NGS is boosting discovery and enabling the personalized medicine future, also revolutionizing fields, such as, genetic diseases and clinical diagnostics with the capability to sequence multiple individuals at the same time.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53919
According to the European Bioinformatics Institute (EBI), next-generation sequencing is the catch-all term used to describe a number of modern sequencing technologies including, the roche 454 sequencing, illumina (solexa) sequencing, SOLiD sequencing, and ion torrent: proton / PGM sequencing.
The global NGS services market is primarily driven by factors, such as, plunging cost of sequencing, technological advancements in NGS, increasing requirement for skilled professionals for efficient sample preparation and analysis of NGS, exorbitant cost of sequencing infrastructure, and expansion in genome mapping programs.
Moreover, rising applications in agrigenomics and oncology research and need for complex sequencing data analysis provides major opportunities for NGS service providers. However, installation of in-house sequencing facilities in hospitals and universities is anticipated to hinder the growth of next-generation sequencing (NGS) services market in the near future.
Request for ToC – https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=53919
In terms of service type, the next-generation sequencing (NGS) services market can be segmented into targeted sequencing, exome sequencing, RNA sequencing, de novo sequencing, whole genome sequencing, ChIP-sequencing, methyl sequencing, and other services. Based on technology, the next-generation sequencing (NGS) services market can be classified into ion semiconductor sequencing (IOS), single molecule real time sequencing (SMRT), sequencing by synthesis (SBS), nanopore sequencing, and true single molecule sequencing (tSMS).
In terms of application, the next-generation sequencing (NGS) services market can be divided into diagnostics, biomarker discovery, drug discovery, agriculture & animal research, and other applications. In terms of end-user, the next-generation sequencing (NGS) services market can be segmented into academic & research Institutes, hospitals & clinics, pharmaceutical & biotechnology industry, and others.
Request for Report Methodology – https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=53919
Based on geography, the next-generation sequencing (NGS) services market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market due to factors, such as, effective regulatory guidelines regarding approval and use of genetic tests, well-entrenched network of informatics, and strong presence of prominent leaders in the region.
Moreover, increasing number of FDA approved genomic tests in the U.S., rising high burden of infectious and chronic diseases, growing R&D expenditure, and rising awareness regarding NGS services are driving the next-generation sequencing (NGS) services market in North America. Asia Pacific is expected to be the fastest growing market for NGS services due to factors, such as, growing population, increasing prevalence of diseases, initiatives taken by government toward public health maintenance, and rise in research and development in diagnostics.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=53919
Key players functioning in the global next-generation sequencing (NGS) services market are BGI, Illumina, Inc., Novogene Corporation, Veritas, QIAGEN, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., Genotypic Technology Pvt Ltd, and SciGenom Labs Pvt. Ltd. For gaining competitive advantage in the market, these players are involved actively in different growth strategies, such as, partnerships, agreements, collaborations, and new product development.
More Trending Reports by Transparency Market Research –
Medical Imaging Equipment Services Market: The global medical imaging equipment services market is anticipated to reach US$ 29.2 Bn by the end of 2031.
Ultra-large Volume Wearable Injectors Market: The global ultra-large volume wearable injectors market is anticipated to exceed US$ 6.6 Bn by the end of 2031.
Ambulance Services Market: The global ambulance services market is anticipated to reach more than US$ 70 Bn by the end of 2031.
Depth of Anesthesia Monitoring Devices Market: The global depth of anesthesia monitoring devices market is anticipated to reach US$ 382.4 Mn by the end of 2031.
mHealth Services Market: The global mHealth services market is anticipated to reach US$ 415.6 Bn by the end of 2031.
Healthcare ERP Market: The global healthcare ERP market is expected to reach the value at US$ 9.6 Bn by the end of 2031.
Diabetes Supplements Market: The global diabetes supplements market is expected to reach the value of US$ 13.4 Bn by the end of 2031.
Population Health Management Solutions Market: The U.S. population health management solutions market is expected to reach the value of US$ 34.59 Bn by the end of 2028.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com